Valuation Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-12-12 EST			5-day change	1st Jan Change
4,448.00 ^JPY	-0.51%		+0.86%	+6.39%

12-07	Takeda, Protagonist Report One-Year Rusfertide Gains in PV trial	MT
12-06	Protagonist Therapeutics, Inc. and Takeda Pharmaceutical Company Limited Present Longer-Term Data At ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera	CI

Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	6,229,971	5,423,454	6,762,204	6,564,378	6,749,675	7,026,035	-	-
Change	-	-12.95%	24.68%	-2.93%	2.82%	4.09%	-	-
Enterprise Value (EV) ¹	9,862,522	8,919,170	10,611,015	10,950,330	10,725,175	10,969,702	10,684,754	10,459,114
Change	-	-9.57%	18.97%	3.2%	-2.06%	2.28%	-2.6%	-2.11%
P/E ratio	16.6x	23.8x	21.3x	45.4x	64.6x	39.9x	24.2x	21.8x
PBR	1.2x	0.95x	1.06x	0.9x	1x	1.02x	1.02x	1.02x
PEG	-	-0.6x	0.5x	-0.8x	-2.5x	0.6x	0.4x	2x
Capitalization / Revenue	1.95x	1.52x	1.68x	1.54x	1.47x	1.56x	1.55x	1.53x
EV / Revenue	3.08x	2.5x	2.63x	2.57x	2.34x	2.43x	2.36x	2.28x
EV / EBITDA	9.23x	8.54x	9.19x	11.6x	9.71x	9x	8.6x	8.34x
EV / EBIT	19.4x	19.4x	21.6x	51.1x	31.3x	25.9x	18.8x	17.6x
EV / FCF	16x	8.92x	28.7x	43.4x	15.5x	12x	12.7x	12.5x
FCF Yield	6.26%	11.2%	3.49%	2.31%	6.43%	8.33%	7.88%	7.99%
Dividend per Share ²	180	180	180	188	196	200	203.3	208.6
Rate of return	4.52%	5.15%	4.14%	4.49%	4.44%	4.5%	4.57%	4.69%
EPS ²	240.7	147.1	204.3	92.09	68.36	111.3	183.9	203.7
Distribution rate	74.8%	122%	88.1%	204%	287%	180%	111%	102%
Net sales ¹	3,197,812	3,569,006	4,027,478	4,263,762	4,581,600	4,506,677	4,532,746	4,588,563
EBITDA ¹	1,068,940	1,043,995	1,154,905	942,077	1,103,982	1,219,381	1,242,508	1,254,768
EBIT ¹	509,269	460,844	490,505	214,100	342,600	423,456	567,249	593,304
Net income ¹	376,005	230,059	317,017	144,067	107,900	177,854	292,454	309,815
Net Debt ¹	3,632,551	3,495,716	3,848,811	4,385,952	3,975,500	3,943,666	3,658,719	3,433,079
Reference price ²	3,985.00	3,498.00	4,350.00	4,184.00	4,413.00	4,448.00	4,448.00	4,448.00
Nbr of stocks (in thousands)	1,563,355	1,550,444	1,554,530	1,568,924	1,529,498	1,579,594	-	-
Announcement Date	5/11/21	5/11/22	5/11/23	5/9/24	5/8/25	-	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TAKEDA PHARMACEUTICAL COMPANY LIMITED	39.95x	2.43x	9x	4.5%	45.11B
ELI LILLY AND COMPANY	44.92x	14.86x	32.99x	0.58%	920B
JOHNSON & JOHNSON	20.19x	5.61x	15.54x	2.44%	510B
ABBVIE INC.	51.11x	7.4x	17.52x	2.92%	395B
ROCHE HOLDING AG	18.38x	4.62x	11.57x	3.12%	340B
ASTRAZENECA PLC	27.04x	5.12x	15.2x	1.8%	278B
NOVARTIS AG	18.3x	4.95x	11.64x	3.08%	254B
MERCK & CO., INC.	12.96x	4.23x	9.08x	3.22%	249B
NOVO NORDISK A/S	13.93x	4.98x	10.31x	3.62%	224B
AMGEN INC.	25.04x	5.94x	10.2x	3.01%	171B
Average	27.18x	6.01x	14.30x	2.83%	338.71B
Weighted average by Cap.	30.31x	7.97x	18.61x	2.25%